Literature DB >> 32960959

Systems-based hematology: highlighting successes and next steps.

Jori E May1, Patrick C Irelan2, Kailee Boedeker2, Emily Cahill2, Steven Fein3, David A Garcia4, Lisa K Hicks5, Janice Lawson6, Ming Y Lim7, Colleen T Morton8, Anita Rajasekhar9, Satish Shanbhag10, Marc S Zumberg9, Robert M Plovnick2, Nathan T Connell11.   

Abstract

Systems-based hematology is dedicated to improving care delivery for patients with blood disorders. First defined by the American Society of Hematology in 2015, the idea of a systems-based hematologist arose from evolving pressures in the health care system and increasing recognition of opportunities to optimize the quality and cost effectiveness of hematologic care. In this review, we begin with a proposed framework to formalize the discussion of the range of initiatives within systems-based hematology. Classification by 2 criteria, project scope and method of intervention, facilitates comparison between initiatives and supports dialogue for future efforts. Next, we present published examples of successful systems-based initiatives in the field of hematology, including efforts to improve stewardship in the diagnosis and management of complex hematologic disorders (eg, heparin-induced thrombocytopenia and thrombophilias), the development of programs to promote appropriate use of hematologic therapies (eg, blood products, inferior vena cava filters, and anticoagulation), changes in care delivery infrastructure to improve access to hematologic expertise (eg, electronic consultation and disorder-specific care pathways), and others. The range of projects illustrates the broad potential for interventions and highlights different metrics used to quantify improvements in care delivery. We conclude with a discussion about future directions for the field of systems-based hematology, including extension to malignant disorders and the need to define, expand, and support career pathways.
© 2020 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2020        PMID: 32960959      PMCID: PMC7509880          DOI: 10.1182/bloodadvances.2020002947

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  70 in total

1.  Changing provider behavior: an overview of systematic reviews of interventions.

Authors:  J M Grimshaw; L Shirran; R Thomas; G Mowatt; C Fraser; L Bero; R Grilli; E Harvey; A Oxman; M A O'Brien
Journal:  Med Care       Date:  2001-08       Impact factor: 2.983

2.  Improved blood utilization using real-time clinical decision support.

Authors:  Lawrence T Goodnough; Lisa Shieh; Eric Hadhazy; Nathalie Cheng; Paul Khari; Paul Maggio
Journal:  Transfusion       Date:  2013-10-10       Impact factor: 3.157

3.  Net clinical benefit of hospitalization versus outpatient management of patients with acute pulmonary embolism.

Authors:  P-M Roy; D J Corsi; M Carrier; A Theogene; C de Wit; C Dennie; G Le Gal; A Delluc; T Moumneh; M Rodger; P Wells; E Gandara
Journal:  J Thromb Haemost       Date:  2017-02-25       Impact factor: 5.824

Review 4.  The next chapter in patient blood management: real-time clinical decision support.

Authors:  Lawrence Tim Goodnough; Neil Shah
Journal:  Am J Clin Pathol       Date:  2014-12       Impact factor: 2.493

5.  Mortality among males with hemophilia: relations with source of medical care. The Hemophilia Surveillance System Project Investigators.

Authors:  J M Soucie; R Nuss; B Evatt; A Abdelhak; L Cowan; H Hill; M Kolakoski; N Wilber
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

6.  A Multicenter Trial of Vena Cava Filters in Severely Injured Patients.

Authors:  Kwok M Ho; Sudhakar Rao; Stephen Honeybul; Rene Zellweger; Bradley Wibrow; Jeffrey Lipman; Anthony Holley; Alan Kop; Elizabeth Geelhoed; Tomas Corcoran; Philip Misur; Cyrus Edibam; Ross I Baker; Jenny Chamberlain; Claire Forsdyke; Frederick B Rogers
Journal:  N Engl J Med       Date:  2019-07-07       Impact factor: 91.245

7.  Development of an anticoagulation stewardship program at a large tertiary care academic institution.

Authors:  Maria Padron; Marta A Miyares
Journal:  J Pharm Pract       Date:  2013-12-10

8.  Patient satisfaction in specialized versus nonspecialized adult sickle cell care centers: the PiSCES study.

Authors:  Imoigele P Aisiku; Lynne T Penberthy; Wally R Smith; Viktor E Bovbjerg; Donna K McClish; James L Levenson; John D Roberts; Susan D Roseff
Journal:  J Natl Med Assoc       Date:  2007-08       Impact factor: 1.798

9.  Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus Conference.

Authors:  Markus M Mueller; Hans Van Remoortel; Patrick Meybohm; Kari Aranko; Cécile Aubron; Reinhard Burger; Jeffrey L Carson; Klaus Cichutek; Emmy De Buck; Dana Devine; Dean Fergusson; Gilles Folléa; Craig French; Kathrine P Frey; Richard Gammon; Jerrold H Levy; Michael F Murphy; Yves Ozier; Katerina Pavenski; Cynthia So-Osman; Pierre Tiberghien; Jimmy Volmink; Jonathan H Waters; Erica M Wood; Erhard Seifried
Journal:  JAMA       Date:  2019-03-12       Impact factor: 56.272

10.  Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D).

Authors:  Annie M Young; Andrea Marshall; Jenny Thirlwall; Oliver Chapman; Anand Lokare; Catherine Hill; Danielle Hale; Janet A Dunn; Gary H Lyman; Charles Hutchinson; Peter MacCallum; Ajay Kakkar; F D Richard Hobbs; Stavros Petrou; Jeremy Dale; Christopher J Poole; Anthony Maraveyas; Mark Levine
Journal:  J Clin Oncol       Date:  2018-05-10       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.